258 / 464
258
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
> Comparing dosimetry and toxicity of 5-field IMRT versus VMAT for
prostate and pelvic nodal irradiation
P. Turner (UK), S. Jain, D. Mitchell, J. Harney, F. Houghton,
J. McAleese, D. Stewart, A. Hounsell, D. Irvine, G. Corey, K. Tumelty,
K. Thompson, J. O’Sullivan
EP-1340
> Pelvic SABR with HDR boost in intermediate and high risk prostate
cancer (spare): early results
H.B. Musunuru, A. Deabreu, M. Davidson, A. Ravi, J. Hlou, L. Ho,
P. Cheung, D. Vesprini, S. Liu, W. Chu, H. Chung, L. Zhang,
A. Loblaw (Canada)
EP-1341
> Salvage stereotactic body radiotherapy for lymph node oligorecurrent
prostate cancer
G. Fanetti (Italy), C. Fodor, D. Ciardo, L. Santoro, C.M. Francia, M. Muto,
A. Surgo, D. Zerini, G. Marvaso, G. Timon, P. Romanelli, E. Rondi,
S. Comi, F. Cattani, D.V. Matei, M. Ferro, G. Musi, F. Nolè, O. De Cobelli,
P. Ost, R. Orecchia, B.A. Jereczek-Fossa
EP-1342
> Is stereotactic body radiation therapy a viable option for elderly patients
with prostate cancer?
C. Franzese (Italy), G. D’agostino, L. Di Brina, L. Cozzi, T. Comito,
D. Franceschini, F. De Rose, P. Navarria, E. Clerici, A. Ascolese, A. Tozzi,
C. Iftode, S. Tomatis, M. Scorsetti
EP-1343
> Long-term quality of life after high-dose-rate brachytherapy boost for
prostate cancer
W. Busser (The Netherlands), I. Korfage, S. Aluwini
EP-1344
> Dosimetric effect of seed-based prostate localisation on pelvic lymph
nodes in high-risk prostate cancer
R. Valentine (UK), E. Miguel Chumacero
EP-1345
> Oligorecurrent nodal prostate cancer: long-term results of an elective
nodal irradiation approach
S. Tran (Switzerland), S. Jorcano, T. Falco, G. Lamanna, R. Miralbell,
T. Zilli
EP-1346
> Treatment outcomes with hypofractionated high-dose radiation therapy
for prostate cancer
D. Candini (Spain), F. López Campos, C. Vallejo Ocaña,
M. Martín Martín, A. Hervás Morón
EP-1347